All Stories

  1. Relation of blood-based inflammation conditional networks to key immune health status and Alzheimer’s biomarkers in aging adults

    Article • Neurobiology of Aging, October 2026, Elsevier

    Tara Carlisle

  2. Descriptive Analysis of Retrospective Observational Real-World Evidence of a Monoclonal Anti-Amyloid Therapy Program in a Wide Catchment Specialty Memory Clinic

    Article • Neurology and Therapy, June 2026, Springer Science + Business Media

    Tara Carlisle

  3. Refining the Parkinson’s Disease Risk Estimator for Decline In Cognition Tool (PREDICT)

    Article • Cognitive and Behavioral Neurology, March 2026, Wolters Kluwer Health

    Tara Carlisle

  4. Treatment Characteristics With Lecanemab at the University of Colorado's Advanced Therapy in Neurodegenerative Disorders (ATND) Clinic

    Article • Alzheimer s & Dementia, December 2025, Wiley

    Tara Carlisle

  5. American Neuropsychiatric Association 2025 Annual Meeting Abstracts

    Article • Journal of Neuropsychiatry, July 2025, American Psychiatric Association

    Tara Carlisle

  6. Antiamyloid Monoclonal Antibodies in Alzheimer’s Disease Part 2: Challenges in Dementia Care Delivery System Logistics

    Article • Journal of Neuropsychiatry, June 2025, American Psychiatric Association

    Tara Carlisle

  7. Antiamyloid Monoclonal Antibodies in Alzheimer’s Disease, Part 1: Patient Selection

    Article • Journal of Neuropsychiatry, May 2025, American Psychiatric Association

    James Bateman, Tara Carlisle

  8. Synergistic effects of GFAP and Aβ42 on clinical outcomes: Implications for white matter microstructure and verbal memory

    Article • Alzheimer s & Dementia, December 2024, Wiley

    Tara Carlisle

  9. Synergistic effects of GFAP and Aβ42: Implications for white matter integrity and verbal memory across the cognitive spectrum

    Article • Brain Behavior & Immunity - Health, October 2024, Elsevier

    Tara Carlisle

  10. American Neuropsychiatric Association 2024 Annual Meeting Abstracts

    Article • Journal of Neuropsychiatry, July 2024, American Psychiatric Association

    Tara Carlisle

  11. Frontotemporal Dementia

    Article • January 2024, Elsevier

    Tara Carlisle

  12. Original research: initial development of a pragmatic tool to estimate cognitive decline risk focusing on potentially modifiable factors in Parkinson’s disease

    Article • Frontiers in Neuroscience, October 2023, Frontiers

    Tara Carlisle

  13. Original research: longitudinal evaluation of cognitively demanding daily function using performance-based functional assessment highlights heterogeneous trajectories in cognitive and functional abilities in people with Parkinson’s disease

    Article • Frontiers in Neuroscience, June 2023, Frontiers

    Tara Carlisle

  14. Headache-associated smell hallucinations as a first symptom of Lewy body dementia

    Article • Journal of Neuropsychiatry, January 2023, American Psychiatric Association

    Tara Carlisle

  15. Prognosis in substance abuse-related acute toxic leukoencephalopathy: A scoping review

    Article • Journal of the Neurological Sciences, November 2022, Elsevier

    Tara Carlisle

  16. 2022 American Neuropsychiatric Association Annual Meeting Abstracts

    Article • Journal of Neuropsychiatry, July 2022, American Psychiatric Association

    Tara Carlisle

  17. Clinical Reasoning: An 81-Year-Old Woman Who Insisted the Hospital Was Her Home

    Article • Neurology, October 2021, Wolters Kluwer Health

    Tara Carlisle

  18. Abstracts of the MDS Virtual Congress 2021

    Article • Movement Disorders, September 2021, Wiley

    Dr. Rostyslav V Bubnov, Dr. Lev Kalika, Tara Carlisle

  19. Clinical Reasoning: A 58-year-old woman presents with progressive memory deficits, odd behavior, and falls

    Article • Neurology, February 2020, Wolters Kluwer Health

    Tara Carlisle

  20. Connexin 35b expression in the spinal cord of Danio rerio embryos and larvae

    Article • The Journal of Comparative Neurology, January 2014, Wiley

    Tara Carlisle